Ticker LaunchRegulation A · Tier 1
BioLIfe Sciences Inc
BioLIfe Sciences Inc filed a Tier 1 Regulation A offering statement (Form 1-A) on May 31, 2022 for up to $20M at $0.275 per security. The SEC qualified the offering on Jun 30, 2022.
- Status
- Qualified
- Tier
- Tier 1
- Offering size
- $20M
- Offer price
- $0.275
- Security type
- Equity (common or preferred stock)
- Filed
- May 31, 2022
- Qualified
- Jun 30, 2022
- Industry
- Pharmaceutical Preparations
- State
- NV
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) May 31, 2022
- Final offering circular (253G2)
- All filings on EDGAR CIK 1929281
Other qualified Biotech & pharma Reg A offerings
- CBD Life Sciences Inc.Aug 26, 2022 · $9.5M
- Puraverde Inc.Aug 11, 2022 · $50M
- Oncolyze, Inc.Aug 4, 2022 · $15.3M
- Kurve Therapeutics, Inc.Aug 3, 2022 · $50M
- Aeris Biotechnologies, Inc.Jul 26, 2022 · $15M
- Bioadaptives, Inc.May 11, 2022 · $1.5M